- Preview Available
- Scholarly Journal
Improved overall survival in an anti-PD-L1 treated cohort of newly diagnosed glioblastoma patients is associated with distinct immune, mutation, and gut microbiome features: a single arm prospective phase I/II trial
Nature Communications; London Vol. 16, Iss. 1, (2025): 3950.
DOI:10.1038/s41467-025-56930-7
This is a limited preview of the full PDF
Try and log in through your library or institution to see if they have access.